Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Weber

Showing results (101-110 of 252) with videos related to

Pageof 26
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2008
CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapyNina Khanna, Milos Opravil, Hansjakob Furrer, et al.
Antiviral Therapy|March 26, 2004
Effect of individual cognitive behaviour intervention on adherence to antiretroviral therapy: prospective randomized trialRainer Weber, Lisanne Christen, Stephan Christen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 11, 2009
Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control studyHelen Kovari, Bruno Ledergerber, Ulrich Peter, et al.
The Journal of Infectious Diseases|March 4, 2010
Efficient suppression of minority drug-resistant HIV type 1 (HIV-1) variants present at primary HIV-1 infection by ritonavir-boosted protease inhibitor-containing antiretroviral therapyKarin J Metzner, Pia Rauch, Viktor von Wyl, et al.
Antiviral Therapy|March 9, 2005
Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort studyJim Young, Martin Rickenbach, Rainer Weber, et al.
Open Forum Infectious Diseases|May 22, 2018
Incidental Findings on Coronary Computed Tomography Angiography in Human Immunodeficiency Virus (HIV)-Positive and HIV-Negative PersonsSara Reinschmidt, Teja Turk, Philip E Tarr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2010
Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infectionHelen Kovari, Bruno Ledergerber, Manuel Battegay, et al.
Journal of Virology|November 23, 2007
In vivo efficacy of human immunodeficiency virus neutralizing antibodies: estimates for protective titersAlexandra Trkola, Herbert Kuster, Peter Rusert, et al.
Journal of the International AIDS Society|November 14, 2014
Lack of association between use of efavirenz and death from suicide: evidence from the D:A:D studyColette Smith, Lene Ryom, Antonella d'Arminio Monforte, et al.
The Journal of Infectious Diseases|June 3, 2008
Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort StudyThi Tuyet Nhung Vo, Bruno Ledergerber, Olivia Keiser, et al.
Pageof 26

Showing results (101-110 of 252) with videos related to

Sort By:
Pageof 26
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2008
CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapyNina Khanna, Milos Opravil, Hansjakob Furrer, et al.
Antiviral Therapy|March 26, 2004
Effect of individual cognitive behaviour intervention on adherence to antiretroviral therapy: prospective randomized trialRainer Weber, Lisanne Christen, Stephan Christen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 11, 2009
Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control studyHelen Kovari, Bruno Ledergerber, Ulrich Peter, et al.
The Journal of Infectious Diseases|March 4, 2010
Efficient suppression of minority drug-resistant HIV type 1 (HIV-1) variants present at primary HIV-1 infection by ritonavir-boosted protease inhibitor-containing antiretroviral therapyKarin J Metzner, Pia Rauch, Viktor von Wyl, et al.
Antiviral Therapy|March 9, 2005
Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort studyJim Young, Martin Rickenbach, Rainer Weber, et al.
Open Forum Infectious Diseases|May 22, 2018
Incidental Findings on Coronary Computed Tomography Angiography in Human Immunodeficiency Virus (HIV)-Positive and HIV-Negative PersonsSara Reinschmidt, Teja Turk, Philip E Tarr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2010
Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infectionHelen Kovari, Bruno Ledergerber, Manuel Battegay, et al.
Journal of Virology|November 23, 2007
In vivo efficacy of human immunodeficiency virus neutralizing antibodies: estimates for protective titersAlexandra Trkola, Herbert Kuster, Peter Rusert, et al.
Journal of the International AIDS Society|November 14, 2014
Lack of association between use of efavirenz and death from suicide: evidence from the D:A:D studyColette Smith, Lene Ryom, Antonella d'Arminio Monforte, et al.
The Journal of Infectious Diseases|June 3, 2008
Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort StudyThi Tuyet Nhung Vo, Bruno Ledergerber, Olivia Keiser, et al.
Pageof 26